• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Medical Device Market
Medical Device News
Medical Device Stocks
  • Medical Device Market
  • Medical Device News
  • Medical Device Stocks
medical-device-investing

Dentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2017 Results

Gabrielle Lakusta
Mar. 02, 2018 09:22AM PST
Medical Device Investing

DENTSPLY SIRONA (Nasdaq:XRAY), The Dental Solutions Company, today announced its preliminary financial results for the three and twelve months ended December 31, 2017. As quoted in the press release: Net loss attributable to Dentsply Sirona for the fourth quarter of 2017 was $673.4 million, or a loss of $2.95 per diluted share, compared to net …

DENTSPLY SIRONA (Nasdaq:XRAY), The Dental Solutions Company, today announced its preliminary financial results for the three and twelve months ended December 31, 2017.

As quoted in the press release:

Net loss attributable to Dentsply Sirona for the fourth quarter of 2017 was $673.4 million, or a loss of $2.95 per diluted share, compared to net income of $107.0 million, or $0.46 per diluted share in the fourth quarter of 2016.  GAAP loss included a non-cash goodwill impairment charge of $581.0 million and an indefinite-lived intangible asset impairment charge of $266.9 million both driven by management’s projections, tax reform and foreign exchange rate changes. On an adjusted basis, excluding certain items, non-GAAP net earnings per diluted share were $0.82 compared to $0.67 in the fourth quarter of 2016.  A reconciliation of the non-GAAP measures to earnings per share calculated on a US-GAAP basis is provided in the attached tables.

Click here to read the full press release.

medical-device-investing financial-results
The Conversation (0)

Go Deeper

AI Powered
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

Spectral Announces Third Quarter Results

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Medical Device Investing Stocks

Cardiex Limited

Cardiex Limited (CDX:AU)
CDX:AU

Cleo Diagnostics

Cleo Diagnostics (COV:AU)
COV:AU

Avricore Health

Avricore Health (AVCR:CC)
AVCR:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES